Two multicenter, randomized, double-blind, vehicle-controlled studies were conducted with K-301 (Kaprolac[R]) containing urea, lactic acid and propylene glycol in the treatment of scalp seborrheic dermatitis. Another version of K-301 (K-301b) containing isopropyl alcohol was also tested in one study. In study 1 patients were randomized to K-301 and K-301b (n = 51) or vehicle (n = 47) for once-daily treatment for 4 weeks followed by 4 weeks of maintenance treatment 3 times/week. In study 2, patients were randomized to 4 weeks of K-301a once daily (n = 136) or vehicle (n = 65). The erythema and desquamation score at week 4 was the primary endpoint in both studies. The mean ...